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Abstract
The present investigation addresses the problem of the binding mode of phenolic inhibitors and the substrate ascorbate
to the active site of ascorbate oxidase. The results from both types of compounds indicate that the binding site is located
in a pocket near the type 1 copper center. This information is of general interst for blue multicopper oxidases. Docking
calculations performed on the ascorbate oxidase–ascorbate complex show that binding of the substrate occurs in a pocket
near type 1 Cu, and is stabilized by at least five hydrogen bonding interactions with protein residues, one of which involves
the His512 Cu ligand. Similar docking studies show that the isomeric fluorophenols, which act as competitive inhibitors
toward ascorbate, bind to the enzyme in a manner similar to ascorbate. The docking calculations are supported by 19F NMR
relaxation measurements performed on fluorophenols in the presence of the enzyme, which show that the bound inhibitors
undergo enhanced relaxation by the paramagnetic effect of a nearby Cu center. Unambiguous support to the location of the
inhibitor close to type 1 Cu was obtained by comparative relaxation measurements of the fluorophenols in the presence of the
ascorbate oxidase derivative where a Zn atom selectively replaces the paramagnetic type 2 Cu. The latter experiments show
that contribution to relaxation of the bound inhibitors by the type 2 Cu site is negligible.
© 2003 Elsevier Ltd. All rights reserved.
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1. Introduction
Ascorbate oxidase (AO) is a dimeric copper-
containing enzyme which catalyzes the four-electron
reduction of dioxygen to water using preferably
l-ascorbate as a substrate. The enzyme belongs to the
family of multicopper blue oxidases which includes
laccases, ceruloplasmin, and other less well characte-
rized enzymes (Solomon, Sundaram, & Machonkin,
1357-2725/$ – see front matter © 2003 Elsevier Ltd. All rights reserved.
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1996). These oxidases contain four copper atoms
per functional unit, which are classified as types 1,
2, and 3 according to their spectroscopic and re-
dox properties (Reinhammar & Malmström, 1981).
Ascorbate oxidase is the first of the blue oxidases to
be structurally characterized (Messerschmidt, Rossi,
Ladenstein, Huber, Bolognesi, Gatti, Marchesini,
Petruzzelli, & Finazzi-Agrò, 1989; Messerschmidt,
Ladenstein, Huber, Bolognesi, Avigliano, Petruzzelli,
Rossi, & Finazzi-Agrò, 1992). X-ray crystallographic
information is now available for a number of AO
derivatives (Messerschmidt, Luecke, & Huber, 1993;
Messerschmidt, 1997). The active site contains the
mononuclear type 1 copper separated by about 12.5 Å
from the trinuclear cluster comprising the types 2 and
3 coppers (Scheme 1). The type 1 copper contains
the canonical two His, Met and Cys ligand set. The
pair of type 3 copper atoms has a total of six histidine
ligands (three His per Cu) in a trigonal prismatic ar-
rangement and is bridged by an OH− (or O2−) group,
which strongly couples the two metal ions and makes
this dinuclear center EPR silent. The type 2 copper
has two histidine ligands and an OH− (or H2O) lig-
and in a trigonal arrangement. The three Cu atoms of
the cluster are all close to each other, with an aver-
age Cu–Cu distance of 3.7 Å and individual distances
within 0.16 Å from this value (Messerschmidt, 1997).
These active site structural features have been sub-
sequently found, basically unchanged, in the X-ray
crystallographic determination of human ceruloplas-
min (Zaitseva, Zaitsev, Card, Moshkov, Box, Ralph,
& Lindley, 1996; Lindley, Zaitseva, Zaitsev, Card,
Moshkov, & Box, 1997) which, on the other hand,
contains two additional type 1 copper centers, and
fungal laccase (Bertrand, Jolivat, Briozzo, Caminade,
Joly, Madzak, & Mougin, 2002; Hakulinen, Kiiskinen,
Kruus, Saloheimo, Paananen, Koivula, & Rouvinen,
2002). With the latter enzyme, recent spectroscopic
studies suggested that multiple forms of the trinuclear
cluster may be present, since the type of magnetic
coupling between the coppers seems to vary with con-
ditions (Fraterrigo, Miller, Reinhammar, & McMillin,
1999; Li, McMillin, & Antholine, 1992; Huang,
Sakurai, Maritano, Marchesini, & Suzuki, 1999;
Gromov, Marchesini, Farver, Pecht, & Goldfarb,
1999).
During activity, the blue copper oxidases couple
the four-electron reduction of dioxygen to water with
one-electron oxidation of four molecules of the sub-
strate. For AO, the fastest and possibly physiological
substrate is l-ascorbate (Kroneck, Armstrong, Merkle,
& Marchesini, 1982; Avigliano & Finazzo-Agrò,
1997), which in the common plant sources of the
enzyme is involved in cell processes associated with
plant growth, protection and development (Arrigoni,
1994; Cordoba & Gonzales-Reyes, 1994; Wheeler,
Jones, & Smirnoff, 1998). The complex mecha-
nism through which the enzyme catalysis proceeds
is far from being understood (Solomon et al., 1996;
Zaitseva et al., 1996; Casella, Monzani, Santagostini,
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De Gioia, Gullotti, Fantucci, Beringhelli, &
Marchesini, 1999). An essential aspect of the cat-
alytic mechanism is the mode of interaction and
reaction of the organic substrate, ascorbate in the case
of AO, with the enzyme. This problem has received
limited attention so far, and only recently the X-ray
structure of a fungal laccase showed that binding of
an arylamine occurs near type 1 copper (Bertrand
et al., 2002). In the case of AO, the problem of sub-
strate binding has been so far approached through
kinetic and inhibition studies (Casella et al., 1999;
Wimalasena & Dharmasena, 1994; Marchesini,
Cappelletti, Canonica, Danieli, & Tollari, 1977;
Gaspard, Monzani, Casella, Gullotti, Maritano, &
Marchesini, 1997). In this paper, we gain a better defi-
nition of the ascorbate binding site in AO by reporting
kinetic and 19F NMR relaxation studies, and docking
calculations on the competitive inhibitory interaction
of fluorophenols with the enzyme. The presence of a
fluorine atom in these molecules bears the advantage
to allow studying relaxation effects in the same aque-
ous buffer solution used in the inhibition studies. In
order to assess the contribution of individual param-
agnetic centers of AO to the relaxation of bound in-
hibitor nuclei, the zinc containing protein derivatives
ZnT2-AO and Zn4-AO have been also studied.
2. Materials and methods
Ascorbate oxidase was isolated and purified from
green zucchini squash (Cucurbita pepo) according to
the procedure of Marchesini and Kroneck (1979). The
protein had optical indices A280/A610 = 24.4 and
A330/A610 = 0.8 in 0.1 M phosphate buffer, pH 5.7.
The enzyme was routinely conserved as microcrys-
tals in ammonium sulphate. Solutions of the enzyme
were obtained after dialysis of the crystals against
the appropriate buffer. Protein concentrations were
determined spectrophotometrically assuming Mr =
140,000 and ε610 = 9700 M−1 cm−1 for the dimeric
enzyme. Buffer solutions were prepared with water
purified in a Millipore Milli-Q system.
UV-Vis spectra were recorded on a diode ar-
ray HP 8452A spectrophotometer equipped with a
thermostated cell holder maintained at 25 ± 0.1 ◦C.
Enzyme activity and inhibition kinetics of ascorbate
oxidation were determined by measuring dioxygen
consumption on an Amel 360 oxygen meter fitted
with a Clark electrode. The activity is expressed in
Dawson units, where 1 Dawson unit = 1mol min−1
ascorbate oxidized (mg enzyme)−1. The present en-
zyme preparation exhibited very high activity, above
3900 Dawson units in 0.1 M phosphate buffer, pH 5.7.
EDTA (1 mg/ml) was added to stabilize ascorbic acid
solutions in the buffer. The concentration of ascorbic
acid was determined from its absorbance at 266 nm
using ε266 = 15,000 M−1 cm−1.
The ZnT2-AO derivative was prepared by addition
of DDC to the native enzyme (in a molar ratio of 10:1);
the blue enzyme solution turned green upon addition
of the reagent. After incubation for about 30 min at
4 ◦C, the brown precipitate was eliminated by centrifu-
gation (about 90 min at 18,700×g). The enzyme solu-
tion was then dialysed for 4 h against 0.1 M phosphate
buffer at pH 5.7 using a collodion bag, in order to
eliminate traces of the Cu–DDC complex previously
formed. Then, ZnSO4 was added for three times to the
enzyme solution, with a molar ratio of 20:1 to the pro-
tein each time. After each addition, the solution was
left at 4 ◦C for 15 min and then dialyzed against 0.1 M
phosphate buffer pH 5.7. Zinc analysis by atomic ab-
sorption gave 2.2 ± 0.2 atoms per protein dimer.
The Zn4-AO derivative was prepared by dialysing
anaerobically the native enzyme for three times (2 h
each time) against a degassed 0.1 M phosphate buffer
solution at pH 7.0 containing KCN (25 mM) and a
small amount of ascorbic acid, in order to eliminate
traces of dissolved oxygen in the solution. The result-
ing colorless apoenzyme solution was dialysed three
times (2 h each time) against 0.1 M phosphate buffer
pH 5.7 containing about 1 mg/ml EDTA, in order to re-
move traces of copper and other ions, and three times
against the same buffer solution without EDTA. Then,
ZnSO4·7H2O was added for three times to the apoen-
zyme solution, with a molar ratio of 20:1 each time.
After each addition, the enzyme solution was left at
4 ◦C for 15 min and then dialysed against 0.1 M phos-
phate buffer pH 5.7. The residual amount of enzyme
containing type 1 Cu was about 10% as estimated from
the A280/A610 ratio in the UV-Vis spectrum. Zinc anal-
ysis of this protein derivative by atomic absorption
gave 7.3 ± 0.5 atoms per protein dimer.
Inhibition studies were performed with the three
isomeric fluorophenols in 0.1 M phosphate buffer pH
5.7, by measuring the activity as a function of ascorbic
884 L. Santagostini et al. / The International Journal of Biochemistry & Cell Biology 36 (2004) 881–892
acid concentration. Typically, the experiments were
carried out with inhibitor concentration ranging from
0 and 50 mM and ascorbic acid concentration vary-
ing from 0 to 3 mM. The enzyme concentration was
about 3 nM. The reaction rate was measured from the
initial slope of the dioxygen consumption curve. The
kinetic and inhibition parameters were obtained from
fitting of the plots of initial rate versus initial ascorbic
acid concentration, along with the appropriate replots
(Segel, 1975).
Relaxation measurements were performed on a
400 MHz Bruker AVANCE NMR spectrometer at
25 ± 0.1 ◦C with a 50 mM solution of inhibitor in
0.1 M phosphate buffer, pH 5.7, containing 50% D2O.
Relaxation time T1 was measured for the fluorine
nucleus of the inhibitor at different enzyme concen-
trations, ranging from 0 to 10−5 M, in order to obtain
information about distance of fluorine from copper
ions contained in the active site of AO. The same
experiments were performed using ZnT2-AO and
Zn4-AO instead of native AO.
Longitudinal relaxation rates were determined using
the standard inversion recovery method (Vold, Waugh,
Klein, & Phelps, 1968). From the values of T1obs
it is possible to calculate T1b, which is the T1 for
the bound inhibitor when this is in fast exchange be-
tween the active site and the bulk solution, from the
equation:
1
T1obs
=
(
1
T1b
− 1
T1f
) [E0]
KI + [I0] +
1
T1f
(1)
where T1f is T1 for the free inhibitor, [E0] and [I0]
are the initial enzyme and inhibitor concentrations, re-
spectively, and KI is the dissociation constant for the
enzyme-inhibitor complex. T1b is related to the para-
magnetic contribution to the relaxation, T1M, through
the equation:
1
T1b
= 1
T1D
+ 1
T1M + τM (2)
where τM is the lifetime for chemical exchange and
T1D corresponds to the diamagnetic contribution to the
relaxation for the bound inhibitor. In the presence of
strong paramagnetic effect, the diamagnetic contribu-
tion can be neglected, and assuming that the exchange
between the free and bound state is fast, Eq. (2) yields
T1b = T1M.
The paramagnetic contribution to the relaxation
rate, (T1M)−1, of the fluorine nucleus of the bound
inhibitor arising from the unpaired electron on the
copper center(s) is related to the copper–fluorine
distance (r) by the Solomon–Bloemberger equation
(Solomon & Bloembergen, 1956; Bertini & Luchinat,
1996). In the present case, since the inhibitor is not
bound to the metal center(s), only the dipolar term is
retained in this equation, while the scalar term can be
neglected (Bertini & Luchinat, 1996).
1
T1M
= 2
15
(µ0
4π
)2 γ2I g2µ2BS(S + 1)
r6
×
(
3τC
1 + ω2I τ2C
+ 7τC
1 + ω2Sτ2C
)
(3)
where µ0 is the permeability of vacuum, ωI and
ωS are nuclear and electronic Larmor angular ve-
locities, respectively, γ I is the gyromagnetic ratio
of the nucleus, g the electron isotropic g-factor, µB
the Bohr magneton, S the spin quantum number of
the electron, and τC the effective correlation time of
the dipolar interaction. In spite of the assumptions
underlying the use of this equation, it proved to be
useful in our previous studies on peroxidases (Casella,
Poli, Gullotti, Selvaggini, Beringhelli, & Marchesini,
1994; Redaelli, Monzani, Santagostini, Casella,
Sanangelantoni, Pierattelli, & Banci, 2002) and ascor-
bate oxidase (Gaspard et al., 1997). In the case of cop-
per enzymes, it is generally assumed that the overall
correlation time is determined by the electronic relax-
ation, and a τC value of 3.5×10−9 s has been estimated
for a variety of copper enzymes (Bertini, Briganti,
Luchinat, Mancini, & Spina, 1985; Williams & Falk,
1986). The same τC value has been employed here.
CD spectra of AO derivatives were recorded on
a JASCO J-500 spectropolarimeter in the range
300–700 nm. The experiments were carried out us-
ing o- and p-fluorophenol as inhibitors, with a con-
centration varying from 0 to 30 mM. The enzyme
concentration was about 10−5 M.
2.1. Docking simulations
The docking algorithm used in the present in-
vestigation, which is an improved version of a
previously reported procedure developed to study
enzyme–substrate interactions (Casella et al., 1999),
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is based on a combined use of random search and total
energy minimization including the relevant degrees
of freedom of the composite system. In particular,
the algorithm is a multi-step optimization, each step
being composed by two parts: the first, of SA type,
is carried out only on the subspace of the mutual
roto-translations, and produces a global minimum of
the intermolecular energy when the two molecules
are considered as rigid bodies. The second part is a
conventional, gradient based, geometry optimization
carried out within the MM approximations and uses
as starting point the minimum reached by the SA
step. The MM calculation allows a complete relax-
ation of the internal degrees of freedom of the inter-
acting molecules, thus keeping into account subtle
effects such as the slight movement of some amino
acid side chains to better accommodate the docking
partner. The SA-MM steps are repeated in cycles,
until the MM total energy of the guest–host com-
posite system is converged. This combined algorithm
has been implemented in a new computer program
(P. Fantucci, L. De Gioia, E. Virzi, to be submitted),
automatically interfaced to the GROMOS96 suite of
programs (Van Gunsteren & Berendsen, 1990), which
provides the MM part of the combined procedure,
as well as the general dictionary for fragments and
forcefield parameters.
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Fig. 1. Structure and partial atomic charges, as obtained by AM1 optimization, of the organic ligands investigated in the present study.
The interaction (docking) energy was calculated as:
Edocking = Ep-s − Ep − Es (4)
where Ep-s is the energy of the protein ligand adduct
obtained from the SA/MM docking optimization, Ep
the energy of the isolated protein after MM optimiza-
tion, and Es the energy of the isolated organic ligand
after MM optimization.
The structural and electronic parameters of all the
small organic molecules used in this study were cal-
culated using the semiempirical method AM1 (Dewar,
Zoebisch, Healy, & Stewart, 1985) and transferred to
the GROMOS96 forcefield. The monoanionic form
of ascorbate was used in the calculations because
this is the most stable form present in physiological
conditions, whereas fluorophenols were described as
neutral molecules. Fig. 1 shows the structures of the
organic ligands used in this study and their associated
partial atomic charge values, as calculated by AM1
optimization. Note that, even if the total −1 charge of
ascorbate can be formally localized on one of the three
exocyclic oxygen atoms, AM1 calculations result in
an almost even distribution of the electron density on
the three atoms, irrespective of the presence of the
proton on the central one. Moreover, the conforma-
tional properties of ascorbate have been investigated
sampling the conformational space produced by the
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Fig. 2. Low energy conformers of ascorbate, as obtained by sampling of the conformational space of ascorbate by AM1 optimization.
discrete rotation (steps of 20◦) along the two C–C
bonds characterizing the diol side chain. The AM1
optimization of the generated structures converged
to four low energy conformers, differing by no more
than 5 kcal mol−1, that were used as starting points
in the docking procedure (see Fig. 2). Note also that
the partial atomic charge values computed for the dif-
ferent conformers of l-ascorbate differ by less than
0.02 a.u. (data not shown).
3. Results
3.1. Kinetics
Like the phenolic compounds studied previously
(Gaspard et al., 1997), the three isomeric fluorophe-
nols inhibit the ascorbic acid oxidation catalyzed by
AO. To determine the type of inhibition, the enzy-
matic reaction was studied over a range of ascorbic
acid concentrations in the presence of several fixed
amounts of the inhibitor. For p-fluorophenol and
m-fluorophenol the inhibition was found to be com-
petitive, as for the phenolic compounds studied be-
fore. With o-fluorophenol, the double reciprocal plots
of initial rates at different inhibitor concentration vs.
ascorbic acid concentration were found to intersect on
the left of the y-axis, indicating mixed type inhibition
(Segel, 1975). Analysis of the kinetic data gave the
inhibition constants for the fluorophenols isomers; for
para KI = 15 ± 4 mM, meta KI = 80 ± 6 mM, and
ortho KI = 36±7 mM and K′I = 116±54 mM, where
the constants correspond to the following association
equilibria:
KI : E + I EI (5)
K′I : ES + I ESI (6)
where E: enzyme, I: inhibitor, and S: substrate. There-
fore, even though o-fluorophenol binds both to the en-
zyme and the enzyme–substrate complex, the former
binding is stronger and is mostly responsible for the
inhibition effect.
3.2. Characterization of ZnT2-AO and Zn4-AO
Replacement of type 2 Cu by Zn leads to the enzy-
matically inactive ZnT2-AO derivative. As expected,
the type 2 Cu features are absent in the EPR spec-
trum of this derivative, which is thus the same as that
we reported for T2D-AO (Casella, Gullotti, Pallanza,
Pintar, & Marchesini, 1991), while the optical and CD
spectra of the enzyme in the near UV-Vis range are
little affected by the metal replacement, since they
are dominated by the type 1 Cu characteristics. The
only appreciable change occurs in the CD range be-
tween 300 and 350 nm, where the weak CD activity
of negative sign of the native protein is significantly
reduced in ZnT2-AO (data not shown). This effect is
due both to type 2 copper depletion, since this cen-
ter also contributes to the absorption intensity in the
300–350 nm range (Casella et al., 1991), and to the
fact that a portion of type 3 copper may remain in the
reduced state in ZnT2-AO, as it is in T2D-AO (Casella
et al., 1991) and in T2D-laccase (Kau, Spira-Solomon,
Penner-Hahn, Hodgson, & Solomon, 1987).
For Zn4-AO the spectral characterization is nec-
essarily limited by the absence of suitable chro-
mophores. The CD spectrum of this derivative in the
aromatic region exhibits less well resolved features
of positive sign at 283, 291 and 296 nm, attributed
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to tyrosine and tryptophan residues, compared to
AO (Casella, Fantucci, Gullotti, & Marchesini, 1984)
and ZnT2-AO. This is indicative of some local
conformational rearrangement occurring on metal
replacement.
3.3. NMR relaxation measurements
The paramagnetic effect of types 1 and 2 cop-
per ions contained in the enzyme active site on the
longitudinal relaxation of 19F nuclei of the bound
fluorophenols could give information about Cu–F
distances in the enzyme–inhibitor complexes. To cal-
culate these distances, T1 was determined for the flu-
orophenol alone and in presence of variable amounts
of AO, ZnT2-AO or Zn4-AO. For the native protein,
paramagnetic contributions to nuclear relaxation can
be expected by types 1 and 2 coppers, whereas type
3 copper is strongly coupled and its contribution can
be neglected. Therefore, the Cu–F distances calcu-
lated for ZnT2-AO–fluorophenol complexes represent
distances of the bound inhibitor nuclei from type 1
copper. The experiments with Zn4-AO were needed
to assess the 1/T1D contribution to the relaxation rate.
On binding to the large protein molecule, the tum-
bling motion of the fluorophenols becomes slower
and this effect must be taken into account in the de-
termination of 1/T1b. Upon subtracting the (small)
contribution to relaxation rate due to binding to the
diamagnetic protein, it was possible to get an esti-
mate of the Cu–F distances for the protein complexes
with o- and p-fluorophenol from the calculated 1/T1b
values, as collected in Table 1. We could not per-
form reliable measurements of the T1b values for
m-fluorophenol in the presence of AO or ZnT2-AO
because progressive additions of the proteins to
the inhibitor solutions in the NMR tube invariably
caused formation of protein precipitates at some
stages.
Table 1
Longitudinal relaxation time for the fluorine nuclei of the bound inhibitors and copper–fluorine distances evaluated with Eq. (3)
Inhibitor δF (ppm)a AO ZnT2-AO
T1b (ms) r(Cu–F) (Å) T1b (ms) r(Cu–F) (Å)
p-Fluorophenol −126.0 3.3 5.9 3.7 6.0
o-Fluorophenol −138.2 2.0 5.4 2.2 5.5
a Fluorine chemical shifts are relative to CFCl3.
3.4. CD and EPR experiments on AO–phenol and
ZnT2-AO–phenol complexes
The CD and EPR spectra of AO and ZnT2-AO in the
presence of the fluorophenols were studied at moderate
concentrations of the inhibitors (up to 50 mM) since
with larger concentrations of these compounds some
denaturation of the proteins occurred. In any case, nei-
ther types of spectra were appreciably affected by the
presence of the inhibitors.
3.5. Docking calculations
The computational investigation of AO was carried
out with the aim of describing which amino acids
forming the active site are involved in molecular recog-
nition and/or electron transfer when organic molecules
such as l-ascorbate (substrate) or fluorophenols (in-
hibitors) interact with the enzyme. The computational
docking study carried out as described under Section 2
and using l-ascorbate as binding donor shows that
His512, one of the ligands of type 1 copper, interacts
directly with the substrate and is possibly involved in
the electron transfer process, whereas His445 and the
other copper ligands are not involved in the recognition
event. A number of interactions between the enzyme
active site and l-ascorbate were observed (Fig. 3):
the NH group of His512 forms a hydrogen bond with
the O3 atom of ascorbate (atoms labeled according
to Fig. 1); the amidic group of Gln353 is hydrogen
bonded to the hydroxyl group O5–H of ascorbate;
the indole NH of Trp362 forms an H-bond with O2;
the carboxylate of G1u443 interacts with O6–H; the
aromatic ring of Trp163 is involved in a stacking in-
teraction with the lactone ring of l-ascorbate and the
side chain of Arg285 forms hydrogen bonds with O4.
This complex between AO and l-ascorbate is charac-
terized by a favorable docking energy and is more sta-
ble by 5 kcal mol−1 with respect to a second complex
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Fig. 3. Lowest energy minimum structure of the AO–ascorbate complex as obtained by computational docking (stereo view). For the sake
of clarity only the side chains of the amino acids involved in ascorbate (ASC) recognition and the copper center have been explicitly shown.
Fig. 4. Low energy minimum structure (the total energy is 5 kcal mol−1 higher with respect to the adduct shown in Fig. 1) of the
AO–ascorbate complex as obtained by computational docking (stereo view). For the sake of clarity only the side chains of the amino acids
involved in ascorbate (ASC) recognition and the copper center have been explicitly shown.
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Fig. 5. Lowest energy minimum structure of the adduct between AO and o-fluorophenol (OFF) as obtained by computational docking
(stereo view). For the sake of clarity only the side chains of the amino acids involved in phenol recognition and the copper center have
been explicitly shown.
located by the GSA/MM procedure where the residues
involved in the l-ascorbate recognition are the same
as those previously described but the orientation of
the substrate in the enzyme active site is slightly dif-
ferent (Fig. 4). In fact, in the latter complex, it is the
O2 atom of l-ascorbate which is involved in hydro-
Fig. 6. Lowest energy minimum structure of the adduct between AO and p-fluorophenol (PFF) as obtained by computational docking
(stereo view). For the sake of clarity only the side chains of the amino acids involved in phenol recognition and the copper center have
been explicitly shown.
gen bonding with His512. In addition, the substrate
forms hydrogen bonds also with Gln353 and Arg285.
The computational results obtained for AO–inhibitor
complexes through the combined GSA/MM meth-
ods are in agreement with the kinetic data, since the
fluorophenols fit to the AO binding site. The three
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AO–fluorophenol complexes obtained sampling the
whole crevice forming the active site and featuring
the lowest intermolecular energy are characterized by
a phenol disposition in the active site which is very
similar to that observed for l-ascorbate. This indi-
cates that the presence of the inhibitor does not allow
proper recognition of l-ascorbate by the enzyme. In
particular, m- and o-fluorophenol are characterized
by a very similar spatial disposition of the aromatic
ring and by the presence of a hydrogen bond between
His512A and the fluorine atom (Fig. 5), whereas
p-fluorophenol adopts a slightly different orientation
due to an H-bond formed between the OH group
and the Serl88B residue that is located on the other
AO monomer forming the dimer (Fig. 6). Note that
Trpl63B plays a crucial role in all cases, being in-
volved in a stacking interaction with the aromatic ring
of the inhibitors. These spatial arrangements result in
Cu–F distances equal to 6.80, 6.96 and 9.11 Å for o-,
m- and p-fluorophenol, respectively. It is worth not-
ing that the substituents on the phenyl ring in o- and
m-fluorophenol are both deeply buried in the active
site, resulting in some unfavorable steric interactions.
On the contrary, p-fluorophenol is less buried result-
ing in a less strained arrangement of the amino acids
forming the active site.
4. Discussion
Ascorbate oxidase can be inhibited by two types of
donor molecules: (i) small inorganic anions such as
azide and fluoride, which bind to the trinuclear cop-
per cluster of the enzyme, where the interaction with
dioxygen occurs (Messerschmidt, 1997; Casella et al.,
1999; Cole, Avigliano, Morpurgo, & Solomon, 1991;
Huang, Sakurai, Maritano, Marchesini, & Suzuki,
1999; Gromov, Marchesini, Farver, Pecht, & Goldfarb,
1999), and (ii) organic donor molecules acting as
competitive inhibitors toward ascorbate, which have
been proposed to bind in a pocket adjacent to the type
1 Cu center (Casella et al., 1999; Gaspard et al., 1997).
From the analysis of a Connolly surface for the X-ray
structure model of AO, Messerschmidt et al. (1992)
identified this pocket as the possible substrate binding
site. A recent X-ray crystal study performed on lac-
case from Trametes versicolor showed that a molecule
of the fungus culture inducer (and very slow substrate)
2,5-xylidine remained entrapped in the binding cavity
near type 1 Cu (Bertrand et al., 2002). This binding
cavity is rather wide (10 Å × 10 Å × 20 Å) and the
aromatic amine is held in position by hydrophobic in-
teractions with a few protein residues and by hydrogen
bonding interactions of the amino group with one of
the type 1 Cu His ligands and an Asp residue (Bertrand
et al., 2002). The model for the AO–substrate interac-
tion emerging from the present docking investigation
shows that the smaller size of the cavity near type 1
Cu allows the establishment of multiple interactions
with ascorbate. Also in this case, one of the type 1
Cu His ligands is hydrogen bonded to the substrate,
but four or five additional residues of the protein are
also hydrogen bonded, and a Trp residue completes
the set of substrate recognition interactions through
stacking with the ascorbate lactone ring. These fea-
tures make substrate binding to AO very tight and
explains the rather high substrate specificity exhibited
by this enzyme (Casella et al., 1999; Wimalasena &
Dharmasena, 1994). In addition, participation of the
type 1 Cu His ligand in the substrate binding inter-
action confirms that this residue represents the site
of electron entry into the enzyme during the catalytic
activity (Bertrand et al., 2002; Gaspard et al., 1997).
Simple phenols can be accommodated within the
AO substrate binding site with a disposition similar
to that assumed by ascorbate. In particular, not only
the phenol molecule is deeply buried into the crevice
formed by the active site, as observed for l-ascorbate,
but also the relative orientations of the phenyl ring
and ascorbate lactone ring are very similar. This result
provides a structural basis to the pattern of inhibition
effects observed for phenolic compounds. It also ac-
counts for the observation that the inhibitory effect is
completely prevented when a substituent of large size
is present on the phenol ring, as in p-tert-butylphenol
(Gaspard et al., 1997), due to space limitation in the
protein cavity. To provide unambiguous experimental
support to the location of the inhibitor binding site,
paramagnetic 19F NMR relaxation measurements on
AO–fluorophenol and ZnT2-AO–fluorophenol com-
plexes were performed. The investigation of the latter
metal substituted AO derivative was necessary to as-
sess the eventual contribution to relaxation by binding
of additional inhibitor molecules in relative proximity
to type 2 Cu. A small effect attributable to this Cu
center actually exists, as shown by comparison of the
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data for AO and ZnT2-AO in Table 1, and is probably
due to nonspecific binding of the fluorophenols on
the protein surface around the trinuclear cluster. For
a thorough interpretation of the data, the small re-
laxation contribution to the bound phenol nuclei due
to the slow tumbling motion of the AO–fluorophenol
complexes had to be subtracted. The diamagnetic
Zn4-AO derivative was selected for this purpose be-
cause it proved to be more resistant to denaturation
than apoAO in the presence of the excess amounts of
the fluorophenols used in the measurements.
Therefore, the NMR relaxation experiments show
that indeed the binding site of the phenolic inhibitors
is close to type 1 Cu and far from the trinuclear cop-
per cluster. The Cu–fluorine distances for the bound
fluorophenols estimated in this way are about 30%
shorter than those allowed by docking calculations
and this certainly reflects the uncertainty in the τC
value employed for the enzyme. On the other hand,
computational procedures cannot take into account
slight conformational rearrangements occurring in the
active site on binding of the inhibitor. This is probably
the reason for the discrepancy of the two approaches
in localizing the position of p-fluorophenol within the
AO cavity. The docking calculations freeze the dispo-
sition of this phenol slightly removed from type 1 Cu,
by overweighing the hydrogen bonding interaction
between the hydroxyl group and the Ser188B residue
with respect to that between the fluorine atom and the
type 1 Cu His512A ligand. The 19F relaxation data
actually agree with a dynamic equilibrium between
two positions for this inhibitor within the AO cav-
ity, because the Cu–F distance for p-fluorophenol is
about 10% larger than that found for o-fluorophenol
(Table 1). In conclusion, the present investigation has
shown the features that make the active site binding
pocket of AO so specific for ascorbate and given a
structural basis for the understanding of the mecha-
nism of AO inhibition by phenolic compounds.
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